STOP-AMDR

STOP-AMDR Project Quarterly Newsletter

Stronger Together: Community Leadership and Country Action Against Antimalarial Drug Resistance

Photo: Ms. Mary Muthoni, Principal Secretary for Public Health and Professional Standards, joins Jhpiego and national health leaders at the April 2026 launch of Kenya’s implementation plan for multiple first-line therapies for uncomplicated malaria treatment, 2026–2030—an important step toward protecting effective treatment and advancing malaria elimination

Dear Colleagues, Partners, and Friends,

Welcome to this edition of the STOP-AMDR newsletter.

As we reflect on the progress highlighted in these pages, I am reminded that the fight against malaria and antimalarial drug resistance is ultimately about people. Behind every policy change, surveillance activity, research study, or community intervention are individuals, families, health workers, and communities working together to protect hard-won gains against one of the world's most persistent public health challenges.

This edition showcases inspiring examples of that collective effort. From communities in Burkina Faso working to improve treatment-seeking behaviors to national programs advancing innovative approaches such as multiple first-line treatments in Nigeria, these stories demonstrate the power of partnership, evidence, and local leadership. They also illustrate an important lesson: progress against malaria requires action at every level—from empowered communities and frontline health workers to strong health systems and responsive national policies.  We are also pleased to introduce the new STOP-AMDR website, which brings together project achievements, country activities, resources, and lessons from across the region. I invite you to explore the site, share it with your networks, and stay connected with our work.

The emergence and spread of antimalarial drug resistance remains a significant threat to malaria control and elimination efforts worldwide. Through STOP-AMDR, we are working alongside governments, research institutions, implementing partners, and affected communities to strengthen surveillance, generate evidence, improve the use of quality-assured treatments, and support country-led solutions that can safeguard the effectiveness of antimalarial medicines for future generations.  

What continues to inspire me is the commitment and collaboration of our partners across countries. Together, we are building a learning network that not only responds to current challenges but also prepares us for those ahead. By sharing experiences, investing in innovation, and strengthening systems, we can ensure that the tools we rely on today remain effective tomorrow.

I would like to thank all those contributing to this important work—our national malaria programs, researchers, health care providers, community leaders, donors, and implementing partners. Your dedication and expertise are critical to our shared mission.

As we move forward, let us continue to learn from one another, strengthen our partnerships, and remain steadfast in our commitment to protecting communities from malaria and the growing threat of drug resistance.

Together, we can sustain progress, save lives, and accelerate the journey toward a malaria-free future.

Sincerely,

Dr Rima Shretta, Project Director, STOP AMDR

Events and Announcements:

The new STOP-AMDR website is live!

Explore the new platform to learn more about our work as we tackle antimalarial drug resistance, discover valuable resources, and follow the progress, partnerships, and innovations driving impact across countries.

#STOPAMDR #Malaria #AMDR #GlobalHealth

Country Highlights:

Burkina Faso

In Burkina Faso’s Pouytenga district, community facilitator Celestine Silga is helping lead efforts to address malaria at the community level. Through home visits and trusted guidance, she is supporting families to recognize symptoms early, move away from self-medication, and seek timely care, helping save lives and protect the most vulnerable.

Click here to read more.

Kenya

The Multiple First Line Therapy (MFT) plan was successfully launched in Kenya, marking a key milestone in expanding secure, scalable digital capabilities in the market. Driven by strong partner collaboration, and local market relevance, the rollout has laid a solid foundation for sustained adoption and growth across malaria prevention and treatment initiatives.  

Read More Here.

Nigeria

Strong partnerships centered on people drive lasting change. During this period, stakeholders in Nigeria moved beyond participation to ownership, helping shape the tools and strategies that will sustain the fight against antimalarial drug resistance. 

Read More Here.

Join STOP-AMDR at ASTMH 2026

The STOP-AMDR team will be at the American Society of Tropical Medicine & Hygiene (ASTMH) 2026 to share emerging evidence, implementation insights, and lessons learned from efforts to prevent antimalarial drug resistance and protect the effectiveness of malaria treatments across Africa.

Read more about our presence at the conference.